Insider Selling: Phreesia, Inc. (NYSE:PHR) CFO Sells 948 Shares of Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 948 shares of Phreesia stock in a transaction on Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $21,671.28. Following the completion of the transaction, the chief financial officer now owns 97,230 shares of the company’s stock, valued at approximately $2,222,677.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Monday, April 8th, Balaji Gandhi sold 7,778 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $175,938.36.
• On Monday, March 25th, Balaji Gandhi sold 3,504 shares of Phreesia stock. The shares were sold at an average price of $23.21, for a total value of $81,327.84.

Phreesia Trading Down 2.3 %

NYSE:PHR opened at $22.62 on Friday. Phreesia, Inc. has a 1-year low of $12.05 and a 1-year high of $34.98. The business’s 50-day moving average price is $24.40 and its two-hundred day moving average price is $21.26. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.78 and a quick ratio of 1.78.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The company had revenue of $95.00 million during the quarter, compared to the consensus estimate of $93.52 million. During the same period in the prior year, the company earned ($0.72) earnings per share. The company’s revenue for the quarter was up 24.0% compared to the same quarter last year. As a group, research analysts expect that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Barclays assumed coverage on Phreesia in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 target price for the company. DA Davidson restated a “neutral” rating and set a $32.00 target price on shares of Phreesia in a research report on Friday, March 15th. Raymond James restated an “outperform” rating and set a $30.00 target price (up previously from $25.00) on shares of Phreesia in a research report on Friday, March 15th. Stephens restated an “overweight” rating and set a $28.00 target price on shares of Phreesia in a research report on Friday, March 22nd. Finally, Canaccord Genuity Group boosted their target price on Phreesia from $36.00 to $37.00 and gave the stock a “buy” rating in a research report on Friday, March 15th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $31.62.

Institutional Investors Weigh In On Phreesia

Large investors have recently modified their holdings of the business. International Assets Investment Management LLC increased its holdings in shares of Phreesia by 1,987.3% in the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after acquiring an additional 1,411 shares in the last quarter. Captrust Financial Advisors grew its holdings in shares of Phreesia by 154.6% during the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after buying an additional 866 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of Phreesia during the first quarter worth about $43,000. State of Wyoming grew its holdings in shares of Phreesia by 34.6% during the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock worth $59,000 after buying an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Phreesia by 85.4% during the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock worth $80,000 after buying an additional 1,445 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.